DecreaseText Size Reset Text Size Increase Text Size
resize Print E-mail
1st Price in Entrepreneurial innovation

The 1st award in the category of “Entrepreneurial Innovation - 2006” was granted to Lavipharm at the 4th Annual Ceremony “Business Awards HRIMA 2006–Georgios Ouzounis”. The event, which took place in Athens on November 2nd, awarded the leading Greek corporations for year 2006 in the context of the International Investors Conference, titled “EUROMONEY”. The objective of this contest is to promote and award the progress of the companies that effectively contribute to the development of the stock market and to the Greek economy in general.

Lavipharm, a pioneer in the Research and Development area in Greece, with significant international activity, was selected 1st by the reading public of “HRIMA”, a Greek financial magazine which initiated the poll. Investing continuously in research laboratories meeting the highest standards, equipped by a specialized scientific team, Lavipharm focuses in pharmaceutical technology research and development with operations in the USA, France and Greece. The recent approval by the American Food and Drug Administration (FDA) for the launch of its first product (a fentanyl transdermal system) in the US market verifies Lavipharm’s vision and strategic decisions.

The company’s sustained growth, continuous investments, innovative ideas and international positioning were the basic criteria for the voters that placed once again Lavipharm to the top.



Copyright© 2011 Lavipharm. All Rights Reserved | Legal Restrictions & Terms of use | Privacy Policy